Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
暂无分享,去创建一个
D C Wheeler | M. Landray | D. Wheeler | C. Baigent | J. Townend | M. Kendall | J N Townend | J. Thambyrajah | C Baigent | M J Kendall | M J Landray | J Thambyrajah | F J McGlynn | H J Jones | H. Jones | F. J. McGlynn
[1] S. Wannamethee,et al. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. , 1997, Stroke.
[2] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[3] P. Nilsson-ehle,et al. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. , 1996, Scandinavian journal of clinical and laboratory investigation.
[4] D. Wheeler,et al. Low-density lipoprotein subfraction profiles in chronic renal failure. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[5] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] M. Sokolow,et al. The ventricular complex in right ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.
[7] D. Serur,et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] D. Bates,et al. Relationship between hematocrit and renal function in men and women. , 2001, Kidney international.
[9] G. London,et al. Atherosclerosis and arteriosclerosis in chronic renal failure. , 1997, Kidney international.
[10] P. Barie,et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. , 1996, Critical care medicine.
[11] David C. Murray,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.
[12] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[13] A. Hutchison,et al. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. , 1988, Clinical chemistry.
[14] W. Bartlett,et al. Measurement of plasma total homocysteine by HPLC with coulometric detection. , 1999, Clinical chemistry.
[15] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[16] M. Salvadori,et al. Lipids and apolipoproteins change during the progression of chronic renal failure. , 1992, Clinical nephrology.
[17] N. Rifai,et al. Three generations of high-density lipoprotein cholesterol assays compared with ultracentrifugation/dextran sulfate-Mg2+ method. , 1997, Clinical chemistry.
[18] S. Volpato,et al. Acute Phase Markers Are Associated with Reduced Plasma Lipid Levels in a Population of Hospitalized Elderly Patients , 1999, Gerontology.
[19] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[20] W. März,et al. Lipoproteins and apolipoproteins during the progression of chronic renal disease. , 1988, Nephron.
[21] P. Attman,et al. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis. , 1991, Nephron.
[22] I. Rosenberg,et al. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[23] B. Scribner,et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. , 1974, The New England journal of medicine.
[24] A. Irish,et al. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. , 1998, Atherosclerosis.
[25] J. Gore,et al. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. , 1984, The American journal of cardiology.